Methods| The study included individuals who had received an mRNA COVID-19 vaccine in
pregnancy or were infected with SARS-CoV-2 at 20 to 32 weeks’ gestation, had enrolled in a …

The availability of three COVID-19 vaccines in the United States provides an unprecedented
opportunity to examine how vaccine platforms and timing of vaccination in pregnancy …

COVID-19 vaccination in pregnancy generates functional anti-Spike IgG antibodies that are
known to cross the placenta. However, the durability of vaccine-induced maternal anti-S IgG …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
Coronavirusdisease 2019 (COVID-19), has posed a serious global health threat since its …

As SARS-CoV-2 infections and death counts continue to rise, it remains unclear why some
individuals recover from infection, whereas others rapidly progress and die. Although the …

Substantial immunological changes occur throughout pregnancy to render the mother
immunologically tolerant to the fetus and allow fetal growth. However, additional local and …

SARS-CoV-2 infection causes more severe disease in pregnant women compared to age-matched
non-pregnant women. Whether maternal infection causes changes in the transfer of …

Neonates are born with an immature immune system and rely on the transfer of immunity
from their mothers. Maternal antibodies are transferred via the placenta and breast milk. …

Mpox virus (MPXV) caused a global outbreak in 2022. Although smallpox vaccines were
rapidly deployed to curb spread and disease among those at highest risk, breakthrough …

Preexisting cross-reactive antibodies have been implicated in both protection and
pathogenesis during subsequent infections with different dengue virus (DENV) serotypes (DENV1-4). …